Enterprise Value
135.4M
Cash
8.416M
Avg Qtr Burn
-6.384M
Short % of Float
0.64%
Insider Ownership
19.62%
Institutional Own.
22.57%
Qtr Updated
09/30/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
YTX-7739 Details Parkinson's disease | Phase 2 Update |